{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-023553","form_type":"8-K","ticker":"ROIV","cik":"0001635088","company_name":"Roivant Sciences Ltd.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.143322+00:00","generated_at":"2026-05-18T19:24:23.776554+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Roivant Sciences authorizes $500M share repurchase program","bullets":["New $500M buyback authorization effective June 24, 2025, in addition to prior $1.5B program now exhausted.","Program has no expiration date; funded from available cash and cash equivalents.","Repurchases may be executed via open market, tender offers, or 10b5-1 trading plans.","Timing and size depend on market price, business conditions, and other investment opportunities.","The program may be suspended or discontinued at any time at the company's discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-023553","json":"https://secwatch.observer/filing/0001140361-25-023553.json","markdown":"https://secwatch.observer/filing/0001140361-25-023553.md","text":"https://secwatch.observer/filing/0001140361-25-023553.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125023553/0001140361-25-023553-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1635088/000114036125023553/ef20051006_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T19:24:23.776554+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}